F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, review of list of medications available in emergency box, staff interview, and policy
review, the facility failed to administer a medication as per resident request and physician order. The
affected one (#65) out of the three residents reviewed for medications administered as ordered. The facility
census was 59.
Findings include:
Review of the medical record for Resident #65 revealed an admission date of 12/04/24 with medical
diagnoses of Coronavirus Disease 2019 (COVID-19), acute respiratory failure, chronic obstructive
pulmonary disease, morbid obesity, hypertensive heart disease, and congestive heart failure. The medical
record indicated Resident #65 discharged to a hospital on [DATE].
Review of the medical record for Resident #65 revealed a discharge Minimum Data Set (MDS) assessment,
dated 12/05/24, which indicated Resident #65 was dependent upon staff for toilet hygiene, bathing, and
transfers, and required partial/moderate staff assistance for bed mobility and set-up assistance for eating.
The MDS indicated Resident #65 had oxygen and had shortness of breath with exertion. No respiratory
therapy was indicated on the MDS.
Review of the medical record for Resident #65 revealed a physician order dated 12/04/24 for
ipratropium-albuterol inhalation solution 0.5-2.5 (3) milligram (mg) per 3 milliliters (ml) to give one
application inhale orally every six hours as needed for shortness of breath.
Review of the medical record for Resident #65 revealed a nurse progress note, dated 12/04/24 at 7:29 P.M.,
which stated Resident #65 requested a breathing treatment. The note stated the nurse contacted the
on-call Nurse Practitioner (NP) who ordered Duonebs (ipratropium-albuterol inhalation solution) every six
hours for seven days and the orders were updated.
Review of the medical record for Resident #65 revealed the Medication Administration Record (MAR) for
December 2024 revealed no documentation to support Resident #65 received a breathing treatment on
12/04/24. Review of the MAR revealed Resident #65 received ipratropium-albuterol inhalation solution as
ordered on 12/05/24 at 12:00 A.M.
Review of the medical record for Resident #65 revealed hospital documentation, dated 12/05/24, which
stated Resident #65 was admitted to the hospital for acute hypoxic respiratory and was treated for
myocardial infarction and pulmonary edema.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365773
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365773
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Laurels of Kettering
694 Isaac Prugh Way
Kettering, OH 45429
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the list of medications available in the facility emergency box (ebox) revealed documentation to
support ipratropium-albuterol inhalation solution 0.5-2.5 (3) mg per 3 ml was available in the ebox for
administration.
Interview with on 12/30/24 at 2:00 P.M. with Director of Nursing (DON) confirmed ipratropium-albuterol
inhalation solution 0.5-2.5 (3) milligram per 3 ml was available in the facility ebox for administration to
Resident #65 as requested and per physician orders. DON confirmed the medical record for Resident #65
did not have documentation to support the nurse administered the breathing treatment as requested on
12/04/24.
Review of the facility policy titled, Medication Administration, revised 10/17/23 stated resident medications
are to be administered in an accurate, safe, timely, and sanitary manner. The policy stated medications are
to be administer in accordance with written orders of the attending physician. The policy stated for new
medications to begin routine orders the same day ordered, unless the next dose would be normally given
the next day.
This deficiency represents non-compliance investigated under Complaint Number OH00160573.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365773
If continuation sheet
Page 2 of 2